You are here
- Home
- Drug Products
- All Drug Products
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Extended Release Tablets of AZD3241 after Administration of Multiple Ascending Doses in Healthy Male and Female Volunteers including food effect
- Disease
- Parkinson's disease
- Drug Name
- AZD3241
- Generic Name
- AZD3241
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jun 3, 2009
- Study Name
- D0490C00002
- Study Id
- D0490C00002
- ClinicalTrials.gov ID
- NCT00914303
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
